SLAM
XERS icon

Swiss Life Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Swiss Life Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,232
Closed -$789K – 1745
2026
Q1 		$789K Buy
33,232
+7,173
+28% +$47.6K ﹤0.01% 712
2025
Q4 		$205K Buy
+26,059
New +$205K ﹤0.01% 1275

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Swiss Life Asset Management's XERS Position: Q2 2026 in Review

Swiss Life Asset Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 33,232 shares — an estimated $789K sold.

Swiss Life Asset Management first reported a position in XERS in Q4 2025 and held it in 2 quarters. The position peaked at $789K in Q1 2026. 126 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Swiss Life Asset Management reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Swiss Life Asset Management sold 33,232 Xeris Biopharma Holdings shares in Q2 2026, an estimated $789K.
  • Swiss Life Asset Management first reported a position in Xeris Biopharma Holdings in Q4 2025 and held it in 2 quarters.
  • Swiss Life Asset Management's Xeris Biopharma Holdings position peaked at $789K in Q1 2026.
  • 126 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.